In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

Researchers identified walking impairment and malarial disease sustained by Tutankhamun, supported by the discovery of canes ...

In the first study of its kind, the researchers examined 84 people with temporal lobe epilepsy (epilepsy arising from the temporal lobe at the sides of the head) and hippocampal sclerosis (a condition ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...

Professor John Duncan, Corresponding Author, UCL Queen Square Institute of Neurology In the first study of its kind, the researchers examined 84 people with temporal lobe epilepsy (epilepsy ...

This article is authored by Dr Amit Kumar Agarwal, senior consultant, neurosciences, neurology and stroke medicine, Amrita ...